biblio

Export 6 results:
Filters: Author is Shaligram, Parth S.  [Clear All Filters]
2024
S. M. Suryawanshi, Sahoo, S., Shaligram, P. S., Manna, N., and Samanta, R. C., “Electrochemically enabled (3+2) cycloaddition of unbiased alkenes and β-dicarbonyls”, Chemical Communications, vol. 60, no. 45, pp. 5836-5839, 2024.
A. P. Waghchoure, Sangale, V. B., Shaligram, P. S., Lambud, S., Pardeshi, S. K., Gonnade, R. G., Bandaru, S., More, S., J. Reddy, P., and Bhosale, R. S., “Pyridazine-Based Aggregation Induced Emission Active Conjugates: Synthesis, Single Crystal XRD Analysis, and Self-Assembly Assessment”, CHEMISTRYSELECT, vol. 9, 2024.
C. Hareendran, Shaligram, P. S., Gonnade, R., and Ajithkumar, T. G., “Solid-state NMR method for characterization of pharmaceutical eutectics”, Physical Chemistry Chemical Physics, vol. 26, no. 5, pp. 3800-3803, 2024.
2023
P. S. Shaligram, George, C. P., Sharma, H., Mahadik, K. R., Patil, S., Vanka, K., Arulmozhi, S., and Gonnade, R. G., “Rivaroxaban eutectics with improved solubility, dissolution rates, bioavailability and stability”, Crystengcomm, vol. 25, no. 22, pp. 3253-3263, 2023.
2021
S. H. Thorat, George, C. P., Shaligram, P. S., Suresha, P. R., and Gonnade, R. G., “Polymorphs and hydrates of the anticancer drug erlotinib: X-ray crystallography, phase transition and biopharmaceutical studies”, CrystEngComm, vol. 23, no. 22, pp. 3961-3974, 2021.
2020
C. P. George, Thorat, S. H., Shaligram, P. S., Suresha, P. R., and Gonnade, R. G., “Drug-drug cocrystals of anticancer drugs erlotinib-furosemide and gefitinib-mefenamic acid for alternative multi-drug treatment”, Crystengcomm, vol. 22, no. 37, pp. 6137-6151, 2020.